Xolair 150 mg lyophilized powder for injection Images
Generic Name: omalizumab
This medication has been identified as Xolair 150 mg lyophilized powder for injection. It is supplied by Genentech, Inc.
Xolair is used in the treatment of Urticaria; Food Allergies; Asthma; Nasal Polyps; Chronic Rhinosinusitis With Nasal Polyps and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Xolair 150 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
![Xolair 150 mg lyophilized powder for injection medicine](https://www.drugs.com/images/pills/custom/pill32923-1/xolair.jpeg)
Xolair
- Generic Name
- omalizumab
- Strength
- 150 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0040
More about Xolair (omalizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (221)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.